STAPHYLEX

This brand name is authorized in Nigeria. It is also authorized in Australia, Estonia.

Active ingredients

The drug STAPHYLEX contains one active pharmaceutical ingredient (API):

1	Floxacillin UNII 43B2M34G2V - FLUCLOXACILLIN
	Flucloxacillin is an isoxazolyl penicillin of the β-lactam group of antibiotics which exerts a bactericidal effect upon many Gram-positive organisms including β-lactamase-producing staphylococci and streptococci.
	Read more about Floxacillin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100778	Capsule	STAPHYLEX CAPSULE FLUCLOXACILLIN 500MG CAP 500 mg 10 X 10	10 NF-PP-333843 STAPHYLEX CAPSULE FLUCLOXACILLIN 500MG FLUCLOXACILLIN 500MG, SODIUM STARCH GLYCOLLATE, MAGNESIUM STEARATE, CORN STARCH, COLLOIDAL SILICON DIOXIDE A4-100778 Drugs Imported Products 1010 Prescription Only Medicine (POM) 5/19/2023 MANKIND LIFE-SCIENCES LIMITED, AGGREY ROAD, FEGGE ONITSHA ANAMBRA SCOTT EDIL ADVANCE RESEARCH LABORATOTIES & EDUCATION LTD, Bhatolikalan, Vill Jharmajri, Biddi, INDIA., India	27/03/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CF05	Flucloxacillin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CF Beta-lactamase resistant penicillins
Discover more medicines within J01CF05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10788T, 1526H, 1527J, 5090X, 5091Y
EE	Ravimiamet	1663972
NG	Registered Drug Product Database	A4-100778